Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 414 participants.

Also called NCT02701543

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 414 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02701543
Other papers using this trial's data
  • COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions European heart journal, 2020-07-14 DOI, PubMed 31989155, PMC7360381 In the PMC Open Access subset under CC BY-NC.
  • Low-Dose vs High-Dose Paclitaxel-Coated Balloons for Femoropopliteal Lesions: 2-Year Results From the COMPARE Trial JACC. Cardiovascular interventions, 2022-10-24 DOI, PubMed 36265942

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02701543. Randomized; no masking; primary purpose treatment. Start 2015-10 (actual); primary completion 2018-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease
Condition
Peripheral Artery Disease
Intervention (Device)
Ranger Drug Eluting Balloon
Intervention (Device)
In Pact Drug Eluting Balloon
Lead sponsor
University of Leipzig (class: other)

Record details

Record id
cardio:ct-nct02701543
Content hash
a99ac8570084699ee0aeb483eceb9247c9ac904becfbf48a9c8ec96180768f7c